Targeting group III metabotropic glutamate receptors produces complex behavioral effects in rodent models of Parkinson's disease

Journal of Neuroscience

Volumn 27, Issue 25, 2007, Pages 6701-6711

  Lopez, Sebastien ^a   Turle Lorenzo, Nathalie ^a   Acher, Francine ^b   De Leonibus, Elvira ^c   Mele, Andrea ^c   Amalric, Marianne ^a,d  

^a AIX MARSEILLE UNIVERSITY   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d CNRS   (France)

Author keywords

6 hydroxydopamine; GABAA receptor; Globus pallidus; Metabotropic glutamate receptor; Parkinson's disease; Substantia nigra

Indexed keywords

1 AMINOCYCLOPENTANE 1,3,4 TRICARBOXYLIC ACID; 2 AMINO 4 PHOSPHONOBUTYRIC ACID; 3,4 DICARBOXYPHENYLGLYCINE; ALPHA CYCLOPROPYL 4 PHOSPHONOPHENYLGLYCINE; HALOPERIDOL; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR AGONIST; PICROTOXIN; UNCLASSIFIED DRUG;

AKINESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; CONTROLLED STUDY; DISEASE MODEL; GABAERGIC TRANSMISSION; GLOBUS PALLIDUS; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REACTION TIME; SUBSTANTIA NIGRA;

ANIMALS; CATALEPSY; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; MALE; PARKINSON DISEASE; RATS; RATS, WISTAR; REACTION TIME; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 34250830873     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0299-07.2007     Document Type: Article

References (58)

1. Acher FC, Tellier FJ, Azerad R, Brabet IN, Fagni L, Pin JP (1997) Synthesis and pharmacological characterization of aminocyclopentanetricarboxylic acids: new tools to discriminate between metabotropic glutamate receptor subtypes. J Med Chem 40:3119-3129.
2. Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366-375.
3. Amalric M, Koob GF (1987) Depletion of dopamine in the caudate nucleus but not in nucleus accumbens impairs reaction-time performance in rats. J Neurosci 7:2129-2134.
4. Amalric M, Koob GF (1989) Dorsal pallidum as a functional motor output of the corpus striatum. Brain Res 483:389-394.
5. Amalric M, Moukhles H, Nieoullon A, Daszuta A (1995) Complex deficits on reaction time performance following bilateral intrastriatal 6-OHDA infusion in the rat. Eur J Neurosci 7:972-980.
6. Battaglia G, Busceti CL, Molinaro G, Biagioni F, Traficante A, Nicoletti F, Bruno V (2006) Pharmacological activation of mGlu4 metabotropic glutamate receptors reduces nigrostriatal degeneration in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Neurosci 26:7222-7229.
7. Baunez C, Amalric M (1996) Evidence for functional differences between entopeduncular nucleus and substantia nigra: effects of APV (DL-2-amino-5- phosphonovaleric acid) microinfusion on reaction time performance in the rat. Eur J Neurosci 8:1972-1982.
8. Bradley SR, Standaert DG, Levey AI, Conn PJ (1999a) Distribution of group III mGluRs in rat basal ganglia with subtype-specific antibodies. Ann NY Acad Sci 868:531-534.
9. Bradley SR, Standaert DG, Rhodes KJ, Rees HD, Testa CM, Levey AI, Conn PJ (1999b) Immunohistochemical localization of subtype 4a metabotropic glutamate receptors in the rat and mouse basal ganglia. J Comp Neurol 407:33-46.
10. Breysse N, Baunez C, Spooren W, Gasparini F, Amalric M (2002) Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism. J Neurosci 22:5669-5678.
11. Chapman AG, Talebi A, Yip PK, Meldrum BS (2001) Anticonvulsant activity of a mGlu(4alpha) receptor selective agonist, (1S,3R,4S)-1-aminocyclopentane-1, 2,4-tricarboxylic acid. Eur J Pharmacol 424:107-113.
12. Conn PJ, Pin JP (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37:205-237.
13. Conn PJ, Battaglia G, Marino MJ, Nicoletti F (2005) Metabotropic glutamate receptors in the basal ganglia motor circuit. Nat Rev Neurosci 6:787-798.
14. Correa M, Mingote S, Betz A, Wisniecki A, Salamone JD (2003) Substantia nigra pars reticulata GABA is involved in the regulation of operant lever pressing: pharmacological and microdialysis studies. Neuroscience 119:759-766.
15. Corti C, Aldegheri L, Somogyi P, Ferraguti F (2002) Distribution and synaptic localisation of the metabotropic glutamate receptor 4 (mGluR4) in the rodent CNS. Neuroscience 110:403-420.
16. De Colle C, Bessis AS, Bockaert J, Acher F, Pin JP (2000) Pharmacological characterization of the rat metabotropic glutamate receptor type 8a revealed strong similarities and slight differences with the type 4a receptor. Eur J Pharmacol 394:17-26.
17. DeLong MR (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13:281-285.
18. Feeley Kearney JA, Albin RL (2003) mGluRs: a target for pharmacotherapy in Parkinson disease. Exp Neurol 184 [Suppl 1]:S30-S36.
19. Goudet C, Chapuy E, Alloui A, Acher F, Pin J, Eschalier A (2006) Modulation of inflammatory and neuropathic pain by group III metabotropic glutamate receptors. FENS Abstr A110.6.
20. Herrera-Marschitz M, Ungerstedt U (1987) The dopamine-gamma aminobutyric acid interaction in the striatum of the rat is differently regulated by dopamine D-1 and D-2 types of receptor: evidence obtained with rotational behavioural experiments. Acta Physiol Scand 129:371-380.
21. Jankovic J (2002) Levodopa strengths and weaknesses. Neurology 58:S19-S32.
22. 3H]mazindol autoradiography. J Neurosci 5:1513-1521.
23. Kearney JA, Becker JB, Frey KA, Albin RL (1998) The role of nigrostriatal dopamine in metabotropic glutamate agonist-induced rotation. Neuroscience 87:881-891.
24. Kincaid AE, Albin RL, Newman SW, Penney JB, Young AB (1992) 6-Hydroxydopamine lesions of the nigrostriatal pathway alter the expression of glutamate decarboxylase messenger RNA in rat globus pallidus projection neurons. Neuroscience 51:705-718.
25. Klockgether T, Turski L (1990) NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats. Ann Neurol 28:539-546.
26. Koch M, Fendt M, Kretschmer BD (2000) Role of the substantia nigra pars reticulata in sensorimotor gating, measured by prepulse inhibition of startle in rats. Behav Brain Res 117:153-162.
27. Konieczny J, Wardas J, Kuter K, Pilc A, Ossowska K (2007) The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1- aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats. Neuroscience 145:611-620.
28. Kosinski CM, Risso Bradley S, Conn PJ, Levey AI, Landwehrmeyer GB, Penney Jr JB, Young AB, Standaert DG (1999) Localization of metabotropic glutamate receptor 7 mRNA and mGluR7a protein in the rat basal ganglia. J Comp Neurol 415:266-284.
29. Levy R, Hazrati LN, Herrero MT, Vila M, Hassani OK, Mouroux M, Ruberg M, Asensi H, Agid Y, Feger J, Obeso JA, Parent A, Hirsch EC (1997) Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states. Neuroscience 76:335-343.
30. MacInnes N, Messenger MJ, Duty S (2004) Activation of group III metabotropic glutamate receptors in selected regions of the basal ganglia alleviates akinesia in the reserpine-treated rat. Br J Pharmacol 141:15-22.
31. Maneuf YP, Mitchell IJ, Crossman AR, Brotchie JM (1994) On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus. Exp Neurol 125:65-71.
32. Marino MJ, Williams Jr DL, O'Brien JA, Valenti O, McDonald TP, Clements MK, Wang R, DiLella AG, Hess JF, Kinney GG, Conn PJ (2003) Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson's disease treatment. Proc Natl Acad Sci USA 100:13668-13673.
33. Matsui T, Kita H (2003) Activation of group III metabotropic glutamate receptors presynaptically reduces both GABAergic and glutamatergic transmission in the rat globus pallidus. Neuroscience 122:727-737.
34. Matsumura M, Tremblay L, Richard H, Filion M (1995) Activity of pallidal neurons in the monkey during dyskinesia induced by injection of bicuculline in the external pallidum. Neuroscience 65:59-70.
35. Messenger MJ, Dawson LG, Duty S (2002) Changes in metabotropic glutamate receptor 1-8 gene expression in the rodent basal ganglia motor loop following lesion of the nigrostriatal tract. Neuropharmacology 43:261-271.
36. Moldrich RX, Chapman AG, De Sarro G, Meldrum BS (2003) Glutamate metabotropic receptors as targets for drug therapy in epilepsy. Eur J Pharmacol 476:3-16.
37. Nielsen KM, Soghomonian JJ (2003) Dual effects of intermittent or continuous L-DOPA administration on gene expression in the globus pallidus and subthalamic nucleus of adult rats with a unilateral 6-OHDA lesion. Synapse 49:246-260.
38. Obeso JA, Rodriguez-Oroz MC, Javier Blesa F, Guridi J (2006) The globus pallidus pars externa and Parkinson's disease. Ready for prime time? Exp Neurol 202:1-7.
39. Ossowska K, Wedzony K, Wolfarth S (1984) The role of the GABA mechanisms of the globus pallidus in mediating catalepsy, stereotypy and locomotor activity. Pharmacol Biochem Behav 21:825-831.
40. Oueslati A, Breysse N, Amalric M, Kerkerian-Le Goff L, Salin P (2005) Dysfunction of the cortico-basal ganglia-cortical loop in a rat model of early parkinsonism is reversed by metabotropic glutamate receptor 5 antagonism. Eur J Neurosci 22:2765-2774.
41. Palucha A, Tatarczynska E, Branski P, Szewczyk B, Wieronska JM, Klak K, Chojnacka-Wojcik E, Nowak G, Pilc A (2004) Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats. Neuropharmacology 46:151-159.
42. Paxinos G, Watson C (2005) The rat brain in stereotaxic coordinates, Ed 5. Sydney: Academic.
43. Rouse ST, Marino MJ, Bradley SR, Awad H, Wittmann M, Conn PJ (2000) Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson's disease and related disorders. Pharmacol Ther 88:427-435.
44. Schann S, Menet C, Arvault P, Mercier G, Frauli M, Mayer S, Hubert N, Triballeau N, Bertrand HO, Acher F, Neuville P (2006) Design and synthesis of APTCs (aminopyrrolidinetricarboxylic acids): identification of a new group III metabotropic glutamate receptor selective agonist. Bioorg Med Chem Lett 16:4856-4860.
45. Scheel-Kruger J (1984) GABA in the striatonigral and striatopallidal systems as moderator and mediator of striatal functions. Adv Neurol 40:85-90.
46. Senkowska A, Ossowska K (2003) Role of metabotropic glutamate receptors in animal models of Parkinson's disease. Pol J Pharmacol 55:935-950.
47. Soghomonian JJ, Chesselet MF (1992) Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat. Synapse 11:124-133.
48. Soghomonian JJ, Pedneault S, Audet G, Parent A (1994) Increased glutamate decarboxylase mRNA levels in the striatum and pallidum of MPTP-treated primates. J Neurosci 14:6256-6265.
49. Testa CM, Standaert DG, Young AB, Penney Jr JB (1994) Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J Neurosci 14:3005-3018.
50. Thomas NK, Wright RA, Howson PA, Kingston AE, Schoepp DD, Jane DE (2001) (S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord. Neuropharmacology 40:311-318.
51. Toms NJ, Jane DE, Kemp MC, Bedingfield JS, Roberts PJ (1996) The effects of (RS)-alpha-cyclopropyl-4-phosphonophenylglycine ((RS)-CPPG), a potent and selective metabotropic glutamate receptor antagonist. Br J Pharmacol 119:851-854.
52. Turle-Lorenzo N, Maurin B, Puma C, Chezaubernard C, Morain P, Baunez C, Nieoullon A, Amalric M (2006) The dopamine agonist piribedil with L-Dopa improves attentional dysfunction: relevance for Parkinson's disease. J Pharmacol Exp Ther 319:914-923.
53. Turski L, Klockgether T, Turski WA, Schwarz M, Sontag KH (1990) Blockade of excitatory neurotransmission in the globus pallidus induces rigidity and akinesia in the rat: implications for excitatory neurotransmission in pathogenesis of Parkinson's diseases. Brain Res 512:125-131.
54. Valenti O, Marino MJ, Wittmann M, Lis E, DiLella AG, Kinney GG, Conn PJ (2003) Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse. J Neurosci 23:7218-7226.
55. Wisniecki A, Correa M, Arizzi MN, Ishiwari K, Salamone JD (2003) Motor effects of GABA(A) antagonism in globus pallidus: studies of locomotion and tremulous jaw movements in rats. Psychopharmacology (Berl) 170:140-149.
56. Wittmann M, Marino MJ, Bradley SR, Conn PJ (2001) Activation of group III mGluRs inhibits GABAergic and glutamatergic transmission in the substantia nigra pars reticulata. J Neurophysiol 85:1960-1968.
57. Wittmann M, Marino MJ, Conn PJ (2002) Dopamine modulates the function of group II and group III metabotropic glutamate receptors in the substantia nigra pars reticulata. J Pharmacol Exp Ther 302:433-441.
58. Zhang C, Albin RL (2000) Increased response to intrastriatal L(+)-2-amino-4-phosphonobutyrate (L-AP4) in unilateral 6-hydroxydopamine- lesioned rats. Exp Neurol 165:278-284.